2019 American Society of Clinical Oncology Annual Meeting

May 31-June 4, 2019
Chicago, IL


Exhibition booth #19135

Satellite symposium:
New Era of Biomarker-driven Clinical Trials and Regulatory Approvals in US and China |June 1, 2019

Poster Presentations:

Plasma cell free DNA (cfDNA) based somatic aberrations detected in treatment naïve metastatic hormone sensitive prostate cancer (mHSPC), hormonally ablated mHSPC and metastatic castration resistant prostate cancer (mCRPC) states and their impact on survival. https://meetinglibrary.asco.org/record/175868/abstract

Leave a Reply